Clinical Focus

• Neurology

Administrative Appointments

• Coyote Foundation Professor, Neurology and Neurological Sciences (2007 - present)
• Director, Stanford Stroke Center, Stanford Medical Center (1992 - present)

Professional Education

Internet Links

• Stanford Stroke Center
• Personal Web site

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

Our group’s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of diffusion- and perfusion-weighted MRI to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

Clinical Trials

• Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2) Recruiting
• NeuroThera® Efficacy and Safety Trial - 3 (NEST-3) Recruiting
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial, a Randomized, Double-blind, Multicenter Clinical Trial Recruiting
• TIA Triage Trial and Evaluation of Vascular-Specific Inflammatory BiomarkerLp-PLA2 as a Stratification Tool for TIA Triage and Stroke Risk Recruiting
• Albumin in Acute Stroke (ALIAS) Trial - Part 2 Recruiting

Publications

• The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM. J Cereb Blood Flow Metab. 2012; 32 (1): 50-6
• A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Vora NA, Shook SJ, Schumacher HC, Tievsky AL, Albers GW, Wechsler LR, Gupta R. Stroke. 2011; 42 (3): 645-9
• A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators. Ogata T, Nagakane Y, Christensen S, Ma H, Campbell BC, Churilov L, Olivot JM, Desmond PM, Albers GW, Davis SM, Donnan GA. Stroke. 2011; 42 (6): 1596-601
• Combined spin- and gradient-echo perfusion-weighted imaging. Schmiedeskamp H, Straka M, Newbould RD, Zaharchuk G, Andre JB, Olivot JM, Moseley ME, Albers GW, Bammer R. Magn Reson Med. 2011
• Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovascular syndromes. Olivot JM, Albers GW. Curr Opin Neurol. 2011; 24 (1): 44-9